Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Sungnam, Korea, Republic of Clinical Trials

A listing of Sungnam, Korea, Republic of clinical trials actively recruiting patients volunteers.

RESULTS

Found (61) clinical trials

Observational Study to Investigate the Effectiveness of Eprosartan on Pulse Pressure (Teveten_MS)

Primary Objective -To assess the changes of pulse pressure at 12 weeks Secondary Objectives - To assess the changes of pulse pressure at 4, 24 weeks - To assess the changes of systolic blood pressure and diastolic blood pressure at each visit - Percentage of responder rate* at each visit ...

Phase N/A

0.0 miles

Learn More »

Post Marketing Surveillance Study For Sayana

Post Marketing Surveillance required by Korea MFDS regulation. Select among patients who randomly visit the site who meet the inclusion/exclusion criteria.

Phase N/A

0.0 miles

Learn More »

Preoperative Epidural Labor Analgesia and Postoperative Pain

Parturients who undergo emergency Cesarean section (C-sec) after experiencing labor pain are likely to develop pain-induced central sensitization. The investigators hypothesized that those without epidural labor analgesia undergoing subsequent emergency C-sec would experience more severe postoperative pain or require more analgesia after C-sec compared to those with epidural labor analgesia. ...

Phase N/A

0.0 miles

Learn More »

Korean Post Marketing Surveillance to Observe Effectiveness and Safety of PRISTIQ

The objective of this study is to determine any problems or questions associated with Pristiq after marketing, with regard to the following clauses under conditions of general clinical practice, in compliance with the regulation "Re-examination guideline of new drugs (Ministry of Food and Drug Safety Notification 2013-251, 2013.12.20)". Serious adverse ...

Phase N/A

0.0 miles

Learn More »

A clinical trial seeking patients for a research study for the treatment of Chronic renal failure

The number of ESRD patients is growing at a much faster rate than the total population, with almost 1,000 (941.7) ESRD patients per one million as of 2006. The ESRD prevalence in Korea is ranked as high as 10th globally. The most common underlying diseases of ESRD in Korea include ...

Phase N/A

0.0 miles

Learn More »

Korean Hereditary Breast Cancer Study

1. To find founder mutation in Korean 2. To correlation prevalence with risk evaluation 3. To find risk factors concerning life style

Phase N/A

0.0 miles

Learn More »

Subclinical COronary Atheroscleorosis Updated With Coronary cT Angiography (SCOUT Study)

A large proportion of patients with sudden cardiac death or nonfatal myocardial infarction (MI) had no prior symptom, which emphasizes the importance of early detection and treatment of the underlying subclinical coronary atherosclerosis before they happen. However, there are no powerful screening methods to detect subclinical coronary atherosclerosis until recently. ...

Phase N/A

0.0 miles

Learn More »

Effect and Efficacy of Onyx Zotarolimus-eluting Stent for Coronary Atherosclerosis

Secondary endpoints are Stent thrombosis-24 hours(acute), 30 days(subacute), 1 year(late), every 1 year till 3 years(very-late) after index PCI (percutaneous coronary intervention), Target vessel failure Composite rate of cardiac death and any MI, 3 years Composite rate of all death and any MI Composite rate of all death, any MI, ...

Phase N/A

0.0 miles

Learn More »

Evaluate the Safety and Effectiveness of Sovaldi Treatment Regimens in Patients With Chronic Hepatitis C Virus (HCV) Infection in a Korean Real-World Setting

The objectives of this study are to collect and assess data related to safety and effectiveness of Sovaldi treatment regimens, per the approved prescribing information for Sovaldi, in routine clinical practice and report results to Korean Ministry of Food and Drug Safety (MFDS).

Phase N/A

0.0 miles

Learn More »

Korean Post-marketing Surveillance for Xeljanz

The objective of this study is to identify any problems and questions with respect to the safety and efficacy of Xeljanz during the post-marketing period as required by the regulation of MFDS.

Phase N/A

0.0 miles

Learn More »